Takeda's Biologics License Application (BLA) for Dengue Vaccine Candidate (TAK-003) Granted Priority Review by U.S. Food and Drug Administration
OSAKA, Japan and CAMBRIDGE, Massachusetts - Takeda announced that the U.S. Food and Drug Administration has accepted and granted priority review of the Biologics License Application for TAK-003,... | November 23, 2022
Source: marketscreener.com